To continue using FE Trustnet please choose an edition:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

Are you invested in Standard Life GARS?



You are here: Factsheet

FL AXA Framlington Health PSB

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Mark Hargraves




Primary Asset Class

Fund Size

GBX 0.03m as at 24-Oct-2013

Downloads ( Underlying )

Unit Name

FL AXA Framlington Health PSB





Initial Charge


Unit Currency




Annual Charge



GBX 275.40

Change (Mid)

-2.80 (-1.01%)

Unit LaunchDate


Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 5.56 13.10 23.39 31.27 81.52 124.10
Sector 2.20 5.21 5.70 8.61 22.71 31.28

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 25.07 29.46 9.60 4.28 15.27
Sector 5.16 10.14 6.76 -5.30 8.11

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 70.53
Swiss Equities 9.93
UK Equities 6.14
Money Market 2.70
German Equities 2.58
Israeli Equities 2.01
French Equities 1.24
Japanese Equities 1.18
Irish Equities 1.16
Canadian Equities 0.91
Australian Equities 0.79
South African Equities 0.57
Brazilian Equities 0.26

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
United States 70.53
Switzerland 9.93
United Kingdom 6.14
Cash 2.70
Germany 2.58
Israel 2.01
France 1.24
Japan 1.18
Ireland 1.16
Canada 0.91
Australia 0.79
South Africa 0.57
Brazil 0.26

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 32.66
Healthcare Services & Enabling Technology / Tools 30.11
Devices 18.13
Biotech Product 16.40
Cash 2.70

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Add your comment
Reload Change mode
Enter the words above:
Send comment
Be the first to comment on this Factsheet.